Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Peripheral arterial intervention · Massachusetts | Peripheral arterial intervention · New York | |
|---|---|---|
| Surgeons, 2024 | 34 | 97 |
| Medicare fee-for-service cases | 3,386 | 12,468 |
| Growth since 2019 (Medicare FFS) | −4.6%/yr | −0.1%/yr |
| Forecast cases (Medicare FFS) | 4,060 in 2030 | 16,300 in 2030 |
| Forecast growth | +3.1%/yr to 2030 | +4.6%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.5 | 6.5 |
| Medicare Advantage share | 39% | 57% |
| Out of hospital | 43% (+26 pts since 2019) | 60% (+12 pts since 2019) |
| Cases per surgeon | 100 | 129 |
| Top 10 surgeons' share | 53% | 43% |
| Surgeons growing | 3 | 13 |
| New since the base year | 10 | 22 |
| Likely to stop billing it | 7 by 2026 | 23 by 2026 |
| Forecast miss, 1 year (procedure) | 8% | 8% |
| Company payments per surgeon | $1,915 | $3,358 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.